Chronic Lung Disease
Chronic Lung Disease (CLD) is a condition often seen in premature infants, characterized by ongoing breathing difficulties due to damaged lungs. It can lead to long-term respiratory problems.
Chronic Lung Disease in Premature Babies: OHB-607 Study
We are testing a new drug to see if it helps reduce lung disease in extremely premature infants compared to standard care. The study aims to improve their overall health and development.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 23 weeks and 27 weeks old (gestational age)?
- Do you have any major congenital malformations identified before randomization?
- Did your birth mother have an active COVID-19 infection at birth or a history of severe COVID-19 during pregnancy?
- Does your birth mother have known HIV or hepatitis (B, C, or E) infection?
- Do you have any significant neurological disease identified before randomization?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Oulu University Hospital
Department of Pediatrics, Neonatal-Perinatal Team
Oulu, Finland
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Klinik und Poliklinik für Kinder- und Jugendmedizin Neonatologie und Pädiatrische Intensivmedizin
Dresden, Germany
Universitaetsklinikum Leipzig AöR
Klinik und Poliklinik für Kinder und Jugendliche, Abteilung für Neonatologie
Leipzig, Germany
Sponsor: Ohb Neonatology Limited
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.